Lambert Initiative

Cannabidiol as an Adjunct for the Treatment of Anorexia Nervosa (CAFTAN): An Open Label Pilot Trial with extension in Young People

Chief InvestigatorUniversity SupervisorClosing Date
Sarah-Catherine RodanProfessor Iain McGregor17 Jul, 2023
Chief InvestigatorSarah-Catherine Rodan
University SupervisorProfessor Iain McGregor
Closing Date17 Jul, 2023

About the research trial

Researchers at the InsideOut Institute and Lambert Initiative at the University of Sydney are investigating the safety and efficacy of a new pharmacological treatment, cannabidiol, as an adjunct to Maudsley Family Based Treatment in young persons aged 12-18 with anorexia nervosa.

Cannabidiol is a non-intoxicating component of the Cannabis plant, which is often referred to as CBD. Cannabidiol has been used in clinical trials in young persons with treatment-resistant anxiety disorders showing very promising results. We want to see if it will help treatment for young persons with anorexia nervosa.

Recruitment details

You may qualify if you:

  • Are aged 12-18
  • Have anorexia nervosa
  • Are in the care of a medical practitioner
  • Are willing to commence Maudsley Family Based Treatment
  • Are medically stable

Participation Involves

 If you decide to take part in the research, you would be asked to

  • Have a medical assessment with your GP that will involve blood tests to confirm you are medically stable
  • Take the investigational product, CBD.
  • Attend Maudsley Family-Based Treatment sessions
  • Complete a series of online questionnaires throughout treatment and at 3 and 6 months after treatment ends.

The treatment with CBD will begin at the commencement of MFBT and will continue every day for 12 weeks. In certain circumstances you may have the opportunity to continue taking CBD until the end of MFBT (week 24) as part of this trial.

Your participation to participate in research is voluntary

Reimbursement for participation

  • You will receive the investigational product, CBD, at no expense to you.
  • You will need to be assessed by your GP for medical stability prior to participation and during participation. Appointments with your GP are at your own cost.
  • Appointments with your clinician for Maudsley Family Based treatment are at your own cost.
  • There are no other costs associated with participation in this research study, nor will you be paid.

If you would like to register your interest, you can complete our pre-screening questionnaire here:


Sarah Catherine Rodan